About this Blog
Collaborate to Innovate aims to further public conversation about health care product development, life cycle management, regulatory and patient access. We offer expert insight on current trends, fresh perspective on timely industry news, as well as commentary and discussion of noteworthy articles published in DIA’s member publications: Therapeutic Innovation & Regulatory Science (TIRS) and Global Forum.
About Therapeutic Innovation & Regulatory Science
Therapeutic Innovation & Regulatory Science (TIRS) is the official journal of DIA, publishing bi-monthly. One of the top-rated benefits DIA members receive, TIRS advances health care product discovery, development, regulation, and use through the publication of peer-reviewed articles and commentaries across the spectrum of converting biomedical science into practical solutions to advance human health.
Click here to learn more about TIRS, read the current issue or browse our archives.
About Global Forum
DIA’s digital member magazine offers expert global and regional coverage of the discovery, development, regulation, surveillance, and marketing of health care products, including interviews with thought leaders and topical summaries from educational events.
Click here to learn more about Global Forum, read the current issue, or browse our archives.
DIA is the global forum for knowledge exchange that fosters innovation to raise the level of health and well-being worldwide. Learn more about DIA at: http://www.diaglobal.org/en/about-us.
The opinions expressed in this blog are the opinions of the individual author and may not reflect the opinions of the Drug Information Association, the TIRS Editorial Board, or any individual member. Links to external sources are provided solely as a courtesy to our blog visitors. We are not responsible for and do not endorse or warrant in any way any materials, information, goods or services available through such linked sites or any privacy or other practices of such sites.
Terms and Conditions
DIA maintains this website to enhance the discourse on medical innovation, drug development, and global regulatory information.
The material on this website may contain opinions and other information of third parties, which do not necessarily reflect the views or positions of DIA or the TIRS Editorial Board, or indicate its commitment to a particular course of action.
By posting your comments or materials on the Blog Space, you grant us a non-exclusive, perpetual, royalty-free, world-wide license to use, reproduce, modify, adapt, translate, publish, distribute and display any content you submit to us in any format now known or later developed. If you do not want to grant us these rights, please do not submit your comments or materials to us.
You are to abide by the following rules:
1. Not to promote or advertise, or engage in any other form of marketing, including (without limitation) chain letters or pyramid selling, even if you are acting on behalf of a non-profit-making organization or a charity, not to upload or post any form of spam, multiple submissions to forums or comments which are identical or other forms of promotion for other sites;
2. Not to submit or create any link to, any defamatory, obscene, indecent, lewd, pornographic, violent, abusive, offensive, insulting, threatening, menacing, unlawful or blasphemous material;
3. Not to make any personal attack on any person, firm or company;
4. Not to use our website to collect personal data about other individuals;
5. Not to post content that violates the legal rights of others, in particular, material that contains the intellectual property rights of third parties unless you have obtained all necessary licences and consents to use such content; We will, when necessary, remove, delete, or suspend the whole or any part of the Blog Space or any content posted on them at our discretion and without notice.
6. Not to reveal any personal information about yourself or anyone else (for example, email address, telephone number or postal address);
7. Not to post content that contains viruses or that may damage SAGE’s or another user’s computer;
We do not undertake to keep or make available any material that you or anyone else has contributed to this website for any length of time, and you are advised to make a copy of any material that you wish to keep.